We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.

The AAP recommends providers consider preemptively tapering opioids if prescribing opioids for 5 or more days in children.

Adolescent Tdap and MenACWY vaccination coverage increased, while HPV vaccination coverage remained stable from 2023 to 2024.

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.

ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

The Gates Foundation will fund $2.5 billion in research on gynecological and obstetric care, contraceptives, STIs, and maternal health.

Patients with dermally-based leiomyosarcoma generally have a better prognosis than patients with subcutis-based leiomyosarcoma.

Centenarians had lower disease burden, particularly for CVD, delayed onset of multiple conditions, and fewer cooccurring diseases over time.

Infants with hyperlinear palms and elevated inflammatory markers have greater rates of atopic dermatitis development within 2 years of age.